About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
69 genotypes with 69 annotations displayed of selected term and subterms
Searched Term: increased prostate gland adenocarcinoma incidence
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Acp3tm1Pivi/Acp3tm1Pivi
(B6.Cg-Acp3tm1Pivi) 		increased prostate gland adenocarcinoma incidence J:207558
Apctm1Tno/Apctm1Tno
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA/2) 		increased prostate gland adenocarcinoma incidence J:120308
Artm1Verh/Y
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:172730
Braftm1Mmcm/Braftm1Mmcm
Nkx3-1tm4(cre/ERT2)Mms/Nkx3-1+
Ptentm1Hwu/Pten+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:191327
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(tetO-BRAF*V600E)29Lc/0
Tg(Tyr-rtTA)37Lc/0
(involves: 129/Sv * C57BL/6J * SJL) 		increased prostate gland adenocarcinoma incidence J:144358
Col1a1tm1(tetO-YAP1*)Fcam/Col1a1+
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:222916
Cop1tm2.1Vmd/Cop1+
Tg(Pbsn-cre)4Prb/0
(B6N.CgCop1tm2.1Vmd Ptentm1Hwu Tg(Pbsn-cre)4Prb) 		increased prostate gland adenocarcinoma incidence J:172653
Ctnnb1tm1Mmt/Ctnnb1+
Igs2tm1(CAG-Met)Zsu/Igs2+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 * FVB/N) 		increased prostate gland adenocarcinoma incidence J:284956
Ctnnb1tm1Mmt/Ctnnb1+
Tg(Pbsn-cre)4Prb/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:143034, J:284956
Ergtm1.1Sho/Ergtm1.1Sho
Ptentm1Hwu/Ptentm1Hwu
Tmprss2tm3Sho/Tmprss2tm3Sho
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:212219
Gt(ROSA)26Sortm1(CAG-AR)Zsu/Gt(ROSA)26Sor+
Tg(Osr1-cre)4Mrt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased prostate gland adenocarcinoma incidence J:234601
Gt(ROSA)26Sortm1(CAG-AR)Zsu/Gt(ROSA)26Sortm1(CAG-AR)Zsu
Tg(Osr1-cre)4Mrt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased prostate gland adenocarcinoma incidence J:234601
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+
Ptentm1Mro/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		increased prostate gland adenocarcinoma incidence J:184533
Gt(ROSA)26Sortm1(JAG1)Xin/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)20Fwan/?
(involves: 129S4/SvJae * C57BL/6 * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:238768
Gt(ROSA)26Sortm1(SPOP*F133V)Mrbn/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:239660
Gt(ROSA)26Sortm1(SPOP*F133V)Mrbn/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:239660
Gt(ROSA)26Sortm1(TMPRSS2/ERG)Key/Gt(ROSA)26Sortm1(TMPRSS2/ERG)Key
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:200002
Hprt1tm1(Pbsn*-cre/ERT2)Jir/Y
Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:144357
Hspa5tm1Alee/Hspa5+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/?
(involves: 129 * 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:142106
Igs2tm1(CAG-Met)Zsu/Igs2+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2 * FVB/N) 		increased prostate gland adenocarcinoma incidence J:268934
Krastm1Bbd/Kras+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:143034
Krastm4Tyj/Kras+
Ptentm1Hwu/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:184935
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:184935
Krastm4Tyj/Kras+
Scribtm1.1Phum/Scrib+
Tg(Pbsn-cre)20Fwan/0
(involves: 129S4/SvJae * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:178461
Krastm4Tyj/Kras+
Scribtm1.1Phum/Scribtm1.1Phum
Tg(Pbsn-cre)20Fwan/0
(involves: 129S4/SvJae * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:178461
Mirc1tm2.1Aven/Mirc1tm2.1Aven
Tg(ARR2/Pbsn-MYC)7Key/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL/J) 		increased prostate gland adenocarcinoma incidence J:223213
Msmbtm1Xuan/Msmbtm1Xuan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * CD-1)) 		increased prostate gland adenocarcinoma incidence J:96884
Nkx3-1tm4(cre/ERT2)Mms/Nkx3-1+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:153425
Pscatm1Witt/Psca+
Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:133908
Pscatm1Witt/Pscatm1Witt
Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:133908
Ptentm1Hwu/Pten+
Tg(ARR2/Pbsn-FGF8)3Prb/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:106650
Ptentm1Hwu/Pten+
Tmprss2tm2.1(ETV1)Sho/Tmprss2tm2.1(ETV1)Sho
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:212219
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae) 		increased prostate gland adenocarcinoma incidence J:144810
Ptentm1Hwu/Ptentm1Hwu
Cop1tm2.1Vmd/Cop1tm2.1Vmd
Tg(Pbsn-cre)4Prb/0
(B6N.CgCop1tm2.1Vmd Ptentm1Hwu Tg(Pbsn-cre)4Prb) 		increased prostate gland adenocarcinoma incidence J:172653
Ptentm1Hwu/Ptentm1Hwu
Ptpn1tm1Bpk/Ptpn1tm1Bpk
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:231906
Ptentm1Hwu/Ptentm1Hwu
Tg(CAG-MYC,-GFP*)#Rugg/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA/2) 		increased prostate gland adenocarcinoma incidence J:261540
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129 * 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:142106
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:268934, J:184935, J:212219
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:93902, J:124208
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)20Fwan/?
(involves: 129S4/SvJae * C57BL/6 * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:238768
Ptentm1Mro/Pten+
Tg(KLK3-cre)D4Trp/0
(involves: 129P2/OlaHsd * FVB) 		increased prostate gland adenocarcinoma incidence J:99524
Ptentm1Ppp/Pten+
Tg(Pbsn-TAg)15Tvd/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:103408
Ptentm1Rdp/Ptentm1Rdp
Smad4tm1Rdp/Smad4tm1Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Terttm1Rdp/Tert+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Terttm3Rdp/Terttm3Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:163589, J:100683
Ptentm2Mak/Ptentm2Mak
Tg(KLK3-cre)13Saa/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:214242
Tbx21tm1Glm/Tbx21tm1Glm
Tg(TRAMP)8247Ng/0
(involves: 129S6/SvEvTac * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:88093
Tg(ARR2/Pbsn-MYC)7Key/?
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:223213, J:85480
Tg(C3-1-TAg)cJeg/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:52786, J:46513, J:72324
Tg(H-2K1-Lrp5/Fkbp1a,-luc*)#Dmps/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:206727, J:184212
Tg(H-2K1-Lrp5/Fkbp1a,-luc*)#Dmps/0
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:206727
Tg(Msmb-TAg)183-2Xuan/0
(involves: C57BL/6 * CBA) 		increased prostate gland adenocarcinoma incidence J:80313
Tg(Pbsn-Ar*E231G)7353Ng/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:96117
Tg(Pbsn-ERG*)1Vv/0
(involves: 129S1/SvImJ * C57BL/6J * CBA) 		increased prostate gland adenocarcinoma incidence J:222916
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
(FVB-Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp) 		increased prostate gland adenocarcinoma incidence J:130340
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
Tg(Pbsn-Lrp5/Fkbp1a,-luc*)#Dmps/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:206727
Tg(Pbsn-Hpn,-GFP)DVv/0
Tg(Pbsn-Tag)12T7fRjm/0
(involves: C57BL/6J * CBA * CD-1) 		increased prostate gland adenocarcinoma incidence J:92562
Tg(Pbsn-MYC)6Key/?
(involves: FVB) 		increased prostate gland adenocarcinoma incidence J:85480
Tg(Pbsn-MYC)#Tt/?
(involves: C57BL/6J) 		increased prostate gland adenocarcinoma incidence J:205395
Tg(Pbsn-Tag)12T7fRjm/0
(involves: CD-1) 		increased prostate gland adenocarcinoma incidence J:48623
Tg(Pbsn-Tag)12T10Rjm/0
(involves: CD-1) 		increased prostate gland adenocarcinoma incidence J:68483, J:48623
Tg(Pbsn-TAg)15Tvd/0
(involves: C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:103408
Tg(TRAMP)8247Ng/0
(involves: C57BL/6) 		increased prostate gland adenocarcinoma incidence J:217920, J:65303
Tg(TRAMP)8247Ng/0
(involves: C3H * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:125633
Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:133908
Tg(TRAMP)8247Ng/0
Usp11tm1Tac/Y
(involves: 129 * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:270214
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:204736
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/23/2024
MGI 6.23 		The Jackson Laboratory